Viewing Study NCT01933958


Ignite Creation Date: 2025-12-25 @ 12:21 AM
Ignite Modification Date: 2026-01-06 @ 1:01 AM
Study NCT ID: NCT01933958
Status: COMPLETED
Last Update Posted: 2022-04-01
First Post: 2013-08-29
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Regorafenib Post-marketing Surveillance in Japan
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module